Chronic Lymphocytic Leukemia
Exploring Factors Supporting TKI Discontinuation in Patients With Ph+ ALL
June 27th 2025Recent studies reveal promising outcomes for discontinuing TKI therapy in select patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, suggesting potential long-term remission.
Read More